comparemela.com

Latest Breaking News On - Members of the donga st research center - Page 1 : comparemela.com

NeuroBo Pharmaceuticals DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical MASH Models Compared to Either Treatment, Alone

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that pre-clinical data suggests that DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist,.

United kingdomMonika lewinskaSujin leeHenrikb hansenMarshallh woodworthAhyoung kimMichael feighHoon jungMi kyung kimYuna chaeMichael millerNeurobo pharmaceuticalsDonga st research centerMembers of the donga st research centerContract research organizationExchange commission

NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June

/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,.

United statesUnited kingdomMichael feighAhyoung kimMichael millerYuna chaeSu jin leeHoon jungHenrikb hansenMonika lewinskaSujin leeShun jungMi kyung kimMarshallh woodworthNeurobo pharmaceuticalsAmerican diabetes association

vimarsana © 2020. All Rights Reserved.